Privia Health Group (PRVA) Expected to Announce Earnings on Thursday

Privia Health Group (NASDAQ:PRVA) is expected to issue its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $516.6090 million for the quarter. Individuals can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 26, 2026 at 8:00 AM ET.

Privia Health Group Stock Down 0.6%

Shares of PRVA opened at $21.53 on Wednesday. The company has a market cap of $2.65 billion, a P/E ratio of 165.63, a PEG ratio of 1.52 and a beta of 0.83. Privia Health Group has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The firm’s 50 day moving average price is $23.07 and its 200 day moving average price is $23.43.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on PRVA. JPMorgan Chase & Co. upped their price objective on Privia Health Group from $32.00 to $33.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Citizens Jmp boosted their target price on Privia Health Group from $30.00 to $31.00 and gave the stock a “market outperform” rating in a research note on Friday, November 7th. Citigroup restated a “market outperform” rating on shares of Privia Health Group in a report on Tuesday, January 6th. Stephens reiterated an “overweight” rating and issued a $32.00 price objective on shares of Privia Health Group in a research note on Thursday, December 4th. Finally, BMO Capital Markets initiated coverage on shares of Privia Health Group in a research note on Thursday, November 13th. They set an “outperform” rating and a $30.00 target price on the stock. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Privia Health Group has an average rating of “Moderate Buy” and a consensus price target of $30.54.

Insider Buying and Selling

In other news, CFO David Mountcastle sold 23,887 shares of the company’s stock in a transaction on Friday, December 12th. The shares were sold at an average price of $25.03, for a total value of $597,891.61. Following the completion of the transaction, the chief financial officer owned 172,909 shares in the company, valued at approximately $4,327,912.27. This represents a 12.14% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Matthew Shawn Morris sold 13,647 shares of the stock in a transaction on Friday, December 12th. The shares were sold at an average price of $25.01, for a total transaction of $341,311.47. Following the completion of the transaction, the director directly owned 68,188 shares in the company, valued at $1,705,381.88. This trade represents a 16.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 10.70% of the company’s stock.

Hedge Funds Weigh In On Privia Health Group

Large investors have recently bought and sold shares of the stock. Tower Research Capital LLC TRC boosted its holdings in shares of Privia Health Group by 601.7% in the second quarter. Tower Research Capital LLC TRC now owns 10,547 shares of the company’s stock valued at $243,000 after acquiring an additional 9,044 shares in the last quarter. CIBC Bancorp USA Inc. purchased a new position in Privia Health Group during the third quarter worth about $305,000. Caxton Associates LLP acquired a new stake in Privia Health Group in the second quarter valued at about $329,000. Smartleaf Asset Management LLC boosted its holdings in Privia Health Group by 16.1% in the 4th quarter. Smartleaf Asset Management LLC now owns 14,395 shares of the company’s stock valued at $343,000 after purchasing an additional 1,997 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in Privia Health Group in the 4th quarter valued at approximately $362,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.